Pharmaceutical group · United States
A group of 6 companies with 15 medicines in 3 countries.
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
15 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EFIDAC 24 CHLORPHENIRAMINE MALEATE16mg · Tablet, extended release | Chlorpheniramine | United States | Not marketed | 1994 |
| EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE16mg; 240mg · Tablet, extended release | Brompheniramine, Pseudoephedrine | United States | Not marketed | 1996 |
| PROGESTASERT38mg · Insert, extended release | Progesterone | United States | Not marketed | 1976 |
| TESTODERM4mg/24hr | 6mg/24hr · Film, extended release | Testosterone | United States | Not marketed | 1993 |
| TESTODERM TTS5mg/24hr · Film, extended release | Testosterone | United States | Not marketed | 1997 |
| CONCERTA EXTENDED RELEASE 18MG TABLET | Methylphenidate | Saudi Arabia | Authorised | |
| CONCERTA EXTENDED RELEASE 36MG TABLET | Methylphenidate | Saudi Arabia | Authorised | |
| JURNISTA 16 mg prolonged-release tablet | Hydromorphone | Saudi Arabia | Authorised | |
| JURNISTA 32 mg prolonged-release tablet | Hydromorphone | Saudi Arabia | Authorised | |
| JURNISTA 64 mg prolonged-release tablet | Hydromorphone | Saudi Arabia | Authorised | |
| JURNISTA 8 mg prolonged-release tablet | Hydromorphone | Saudi Arabia | Authorised | |
| MACRODANTIN25 mg / cap · Capsule | Nitrofurantoin | Canada | Cancelled | 1993 |
| OCUSERT PILO 205 mg / imp · Implant | Pilocarpine | Canada | Cancelled | 1975 |
| OCUSERT PILO 4011 mg / imp · Implant | Pilocarpine | Canada | Cancelled | 1975 |
| POLYCITRA-K1.193 g / 4.5 g · Powder | Potassium | Canada | Cancelled | 1996 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 6 | 6 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Canada | 4 | 0 | 4 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Keep ALZA’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.
